Side effects may still occur and vary by patient 4
Your physician will evaluate your condition, answer questions about how to get BPC-157 for recovery, and send your prescription directly to your preferred pharmacy if approved
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
In fact, BPC-157 has actually been studied for its purpose to treat numerous symptomatic injuries and diseases
Reconstitution, aliquoting, and storage parameters should follow institutional SOPs and validated protocols for smallmolecule handling